Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657693 · ClinicalTrials.gov registry record
MRI in BPD Subjects
A clinical trial of Bronchopulmonary Dysplasia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT03657693: Recruiting study of Bronchopulmonary Dysplasia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03657693 is a study of Bronchopulmonary Dysplasia that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 160 participants, below the 231-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657693, a study of Bronchopulmonary Dysplasia, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are wanting to learn more about early development of the lungs and to help them better understand prematurity and the development of a breathing disorder call BPD (Bronchopulmonary Dysplasia)
Primary Outcome
Investigate parenchymal and vascular structures, regional cardiopulmonary function, and dynamic airway collapse in BPD infants during quiet unsedated breathing.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Polysomnography
- DIAGNOSTIC_TEST NICU MRI
Study Locations (1)
Ohio
- Megan Schmitt - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2018-05-04 |
| Est. Completion | 2030-12-31 |
What NCT03657693 shows while recruiting
NCT03657693 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Polysomnography is the first listed.
NCT03657693 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03657693 about?
NCT03657693 is a clinical study titled "MRI in BPD Subjects". The investigators are wanting to learn more about early development of the lungs and to help them better understand prematurity and the development of a breathing disorder call BPD (Bronchopulmonary Dysplasia)
What is the current status of trial NCT03657693?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2018-05-04. Estimated completion is 2030-12-31.
What conditions does trial NCT03657693 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia.
What interventions are being tested in trial NCT03657693?
The interventions under investigation include: Polysomnography (DIAGNOSTIC_TEST), NICU MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03657693?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03657693 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03657693's enrollment target sits among peer trials
160 14th of 29 higher than 16 of 29 other Bronchopulmonary Dysplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI